Do Anticonvulsant Drugs Commonly Induce Osteomalacia?
暂无分享,去创建一个
B. F. Allam | B. Boyce | I. Fogelman | W. Mcintosh | J. Gray | D. Lawson | G. Beastall | M. D. Gardner | I. Boyle
[1] L. Mosekilde,et al. Reduced 2,25-dihydroxyvitamin D and 24,25-dihydroxyvitamin D in epileptic patients receiving chronic combined anticonvulsant therapy. , 1981, Metabolic bone disease & related research.
[2] I. Fogelman. THE VALUE OF 24 HOUR SKELETAL UPTAKE OF DIPHOSPHONATE IN THE EXCLUSION OF METABOLIC BONE DISEASE , 1980 .
[3] T. Clemens,et al. METABOLITES OF VITAMIN D IN HUMAN VITAMIN-D DEFICIENCY: EFFECT OF VITAMIN D3 OR 1,25-DIHYDROXYCHOLECALCIFEROL , 1980, The Lancet.
[4] R. Lindsay,et al. SKELETAL UPTAKE OF DIPHOSPHONATE Method for Prediction of Post-menopausal Osteoporosis , 1980, The Lancet.
[5] I. Fogelman,et al. Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate. , 1980, Annals of internal medicine.
[6] L. Lidgren,et al. Biochemical variables related to calcium metabolism in epileptics. , 2009, Acta medica Scandinavica.
[7] R. Jung,et al. Vitamin D Metabolism in Subjects Receiving Anticonvulsant Drugs , 1979 .
[8] J. Wark,et al. CHRONIC DIPHENYLHYDANTOIN THERAPY DOES NOT REDUCE PLASMA 25‐HYDROXY‐VITAMIN D , 1979, Clinical endocrinology.
[9] Y. Weisman,et al. Decreased serum 24,25-dihydroxy vitamin D concentrations in children receiving chronic anticonvulsant therapy. , 1979, British medical journal.
[10] D. Lawson,et al. Role of nutrition in the development of osteomalacia in the elderly. , 1979, Nutrition and metabolism.
[11] R. Bansal,et al. Occult anticonvulsant osteomalacia in North India. , 1979, Nutrition and metabolism.
[12] A. Parfitt,et al. Osteomalacia: current concepts. , 1978, Annals of internal medicine.
[13] W. Greig,et al. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] R. Retallack,et al. ANTICONVULSANT INDUCED INCREASE IN 25-HYDROXY-VITAMIN D3-lα-HYDROXYLASE , 1977 .
[15] K. T. Palmer,et al. Anticonvulsant-induced osteomalacia. , 1977, Age and ageing.
[16] M. Haussler,et al. Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs. , 1977, The Journal of clinical endocrinology and metabolism.
[17] F. Melsen,et al. Anticonvulsant osteomalacia determined by quantitative analysis of bone changes. Population study and possible risk factors. , 2009, Acta medica Scandinavica.
[18] A. Pierides,et al. Serum gamma glutamyl transferase and alkaline phosphatase activities in epileptics receiving anticonvulsant therapy. , 1976, Clinica chimica acta; international journal of clinical chemistry.
[19] P. D. de Moor,et al. The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. , 1975, The Journal of clinical endocrinology and metabolism.
[20] M. Preece,et al. Studies of vitamin D deficiency in man. , 1975, The Quarterly journal of medicine.
[21] J. A. Madsen,et al. Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children. , 1975, Pediatrics.
[22] J. Haddad,et al. Serum 25-Hydroxycalciferol Levels and Bone Mass in Children on Chronic Anticonvulsant Therapy , 1975 .
[23] B. F. Allam,et al. Abnormalities in mineral metabolism suggestive of parathyroid over-activity in rheumatoid arthritis. , 1975, Current medical research and opinion.
[24] A. Boyo,et al. The effect of long term anticonvulsant therapy on serum calcium, phosphate and alkaline phosphatase in Nigerian epileptic patients. , 1975, Tropical and geographical medicine.
[25] G. Neale,et al. Effect of phenobarbitone treatment on vitamin D metabolism in mammals. , 1974, Clinical science and molecular medicine.
[26] C. Christiansen,et al. Incidence of Anticonvulsant Osteomalacia and Effect of Vitamin D: Controlled Therapeutic Trial , 1973, British medical journal.
[27] N. Maclaren,et al. Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients. , 1973, The Journal of pediatrics.
[28] J. Leonidas. Anticonvulsant Drugs And Vitamin D Metabolism , 1973 .
[29] W. Cooke,et al. Serum alkaline phosphatase and rickets. , 1973, British medical journal.
[30] W. Cooke,et al. Serum Alkaline Phosphatase and Rickets in Urban Schoolchildren , 1973, British medical journal.
[31] J. Haddad,et al. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. , 1972, The New England journal of medicine.
[32] D. Rowe,et al. Plasma Levels and Therapeutic Effect of 25-Hydroxycholecalciferol in Epileptic Patients taking Anticonvulsant Drugs , 1972, British medical journal.
[33] E. Sotaniemi,et al. Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy. , 1972, Annals of internal medicine.
[34] J. Maxwell,et al. Altered Calcium Metabolism in Epileptic Children on Anticonvulsants , 1971, British medical journal.
[35] H. Kazamatsuri. Elevated serum alkaline phosphatase levels in epilepsy during diphenylhydantoin therapy. , 1970, The New England journal of medicine.
[36] A. Richens,et al. Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy , 1970, British medical journal.
[37] A. Richens,et al. Disturbance of Calcium Metabolism by Anticonvulsant Drugs , 1970, British medical journal.
[38] R. Kuntzman. Drugs and enzyme induction. , 1969, Annual review of pharmacology.
[39] R. Kruse. [Osteopathies in antiepileptic long-term therapy (preliminary report)]. , 1968, Monatsschrift fur Kinderheilkunde.
[40] M. Dunnigan,et al. Serum Alkaline Phosphatase in Urban and Semi-Rural Scottish Children , 1965, Scottish medical journal.